Pluristem Therapeutics Inc
Biotechnology
Healthcare
PSTI
32.14 M shares
NASDAQ US
traded
08 Jul 2022
listed
yes
open
1.32
52 week high
4.36
high
1.36
52 week low
1.32
low
1.30
growth
-62.64 %
previous Close
1.33
P/E ratio
market cap
45.93 M
div yield
0
usd
Mar 2022
qoq
revenue
234 K
0.00 %
net incoming
-9.92 M
9.34 %
eps
8.82 %
eps surprise
13.89 %
net profit margin
-4238.46 %
-4238.00 %
operating incoming
-10.48 M
4.25 %
net change in cash
5.71 M
0.00 %
cash on hand
23.79 M
27.12 %
cost of revenue
0.00 %
top top